Navigation Links
Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year
Date:11/10/2008

ets

Cash and cash equivalents $221.7 $131.2

Trade accounts receivable, net of

allowances 395.1 356.2

Inventories 100.0 113.7

Other current assets 55.5 53.4

Total current assets 772.3 654.5

Equipment leased to others, net 171.4 190.2

Property, net 125.4 125.6

Other assets 620.8 629.2

Total Assets $1,689.9 $1,599.5

Liabilities

Current Liabilities

Trade accounts payable $99.4 $89.8

Short-term borrowings 122.6 33.7

Other current liabilities 172.7 169.2

Total current liabilities 394.7 292.7

Long-term debt 100.2 100.6

Other long-term liabilities 112.4 128.6

Total Liabilities 607.3 521.9

Shareholders' Equity 1,082.6 1,077.6

Total Liabilities and Shareholders'

Equity $1,689.9 $1,599.5

Financial Guidance for Fiscal Year 2009

Adjusted 2009 Range

2008 Low High

($ in millions, except EPS)

Net Revenues

Capital sales $1,044 $1,159 $1,194

Rental revenues 464 474 489

Total revenues 1,508 1,633 1,683

YoY % Change
'/>"/>

SOURCE Hill-Rom Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
2. Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results
3. Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update
4. BMP Sunstone Reports Third Quarter 2008 Financial Results
5. Endocare Reports Financial Results for Third Quarter 2008
6. Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
7. Isis Reports Financial Results and Highlights for Third Quarter of 2008
8. OncoGenex Reports Third Quarter Financial Results
9. American Oriental Bioengineering Reports Third Quarter 2008 Financial Results
10. AutoImmune Inc. Reports 2008 Third Quarter Financial Results
11. Dendreon Reports Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... ALTO, Calif. , May 17, 2013 /PRNewswire/ ... it has achieved 50% enrollment of the total ... to evaluate the safety and preliminary efficacy of ... Cells) therapy for Knee Osteoarthritis (KOA). To date ... (SAE) reported. The Phase I open ...
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- Aridis ... been reached with Switzerland -based ... anti-infective human monoclonal antibody (mAb) products, and technologies. ... mAb products for treatment of infections by common ... Staphylococcus aureus , Pseudomonas aeruginosa , ...
(Date:5/17/2013)... May 17, 2013 Men’s skin is biologically ... La-roche Posay ) and has been known to react more ... men may be far from puberty, other acne causing factors ... causing breakouts, and threatening skin with unsightly acne scars. Adult ... Men’s Health on how to reduce and prevent ...
(Date:5/17/2013)... RURO Inc. is pleased to ... versatile refinement to the smart management solution. , ... advanced methodical management for transgenic animal colonies, genotyping ... network-based platform provides user access with a plethora ... to emphasize streamlined tasks, such as animal relocation ...
Breaking Biology Technology:Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2
... VIENNA, Va., March 10 CEL-SCI Corporation (NYSE Alternext ... to launch a new manufacturing process that could allow ... to maintain their potency and thereby potentially also their ... developed by CEL-SCI may also significantly accelerate the time ...
... Take Market Share Away from Lucentis from 2012 ... Decision ResourcesWALTHAM, Mass., March 10 Decision Resources, ... firms for pharmaceutical and healthcare issues, finds that ... macular degeneration (AMD) market through 2012 will be ...
... Tolerx, Inc., today announced that DEFEND ( D urable ... arly or N ew Onset Type 1 D ... targeted immunotherapeutic, has begun enrollment of new onset autoimmune type ... cell function subsequent to the administration of otelixizumab is the ...
Cached Biology Technology:CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products 2CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products 3CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products 4Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe 2Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe 3Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe 2Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe 3Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe 4
(Date:5/16/2013)... predict the stability of today,s largest ice sheets in Greenland ... years ago, for example when Earth was going through ... a high sea level due to ice sheet collapse at ... that if the world,s largest ice sheets collapsed in the ... modern, progressively warming world. , However, a new groundbreaking ...
(Date:5/16/2013)... layer lining the body,s blood vessels, is extremely ... thickness, this super-tenuous structure routinely withstands blood flow, ... a unique and highly dynamic barrier that maintains ... body,s circulatory system. , It,s also extremely adaptable. ... breached to enable immune cells to reach ...
(Date:5/16/2013)... , May 16, 2013 Integrated ... combination with a custom thin film transistor camera ... forensic quality roll image in the smallest and ... Sherlock, an Appendix F Mobile ID FAP 45, ... 95% reduction in size and weight when compared ...
Breaking Biology News(10 mins):World's biggest ice sheets likely more stable than previously believed 2Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4
... the first time, scientists have described not only the identities ... in this case, a mouse macrophage or white blood ... and change over time to a bacterial stimulus triggering the ... of the Journal of Biological Chemistry , lead author ...
... of time, the colonial hydrology of the northeastern U.S. has ... social scientists. The results, which extend as far back ... the journal Environmental Science & Technology (ES&T). ... of the past, and will lead to a better understanding ...
... / ST. PAUL (December 1, 2010) University of ... is among an international group of researchers that has ... of sexual maturation in women. Many of these genes ... energy metabolism. Prior to the multi-institutional study, only four ...
Cached Biology News:Researchers describe first functioning 'lipidome' of mouse macrophage 2Researchers describe first functioning 'lipidome' of mouse macrophage 3America's colonial hydrologic history recreated 2U of M researcher helps unlock 30 new genes responsible for early onset puberty 2
quantitation of phosphatase activity, evaluation of hits and leads from HTS...
... ISO 9001:2000 Certified USDA Research Registered ... SOP's Training AALAS Certified Technicians ... Procedures GLP Documentation Upon Request Focus ... point for all your custom immunology service ...
Request Info...
Request Info...
Biology Products: